Skip to main content

D. E. Shaw & Co., Inc.

Position in ONC — BeOne Medicines Ltd.

CIK 1009207 New York, NY

Position in ONC

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
9 quarters on record

Common Shares in ONC Over Time

Shares Held

Position Value (USD)

Derivatives in ONC

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$475,152
PutShares
1,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ONC

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $475,152 1,600
2025-12-31 $638,001 2,100
2025-12-31 $729,144 2,400
2025-09-30 $545,120 1,600
2025-06-30 $38,295,474 158,200
2025-06-30 $387,312 1,600
2025-03-31 $38,260,025 140,574
2023-12-31 $491,841 2,727
2022-03-31 $1,169,320 6,200
2022-03-31 $1,886,000 10,000
2021-12-31 $1,679,766 6,200
2020-12-31 $13,208,896 51,120